Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.
about
Impact of notch signaling on inflammatory responses in cardiovascular disordersThe migraine-stroke connection: A genetic perspective.The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis--a case control pilot study.Endothelial cells and human cerebral small vessel disease.l-arginine and l-NMMA for assessing cerebral endothelial dysfunction in ischaemic cerebrovascular disease: A systematic review.Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects.CADASIL mutations and shRNA silencing of NOTCH3 affect actin organization in cultured vascular smooth muscle cells.Expert Review of Neurotherapeutics: recent stroke highlights.CADASIL management or what to do when there is little one can do.Genetic animal models of cerebral vasculopathies.Migraine and genetic and acquired vasculopathies.CADASIL: experimental insights from animal models.Migraine and small vessel diseases.Migraine and neurogenetic disorders.Vascular risk in migraineurs: interaction of endothelial and cortical excitability factors.We have contact: endothelial cell-smooth muscle cell interactions.Effect of ST36 Acupuncture on Hyperventilation-Induced CO 2 Reactivity of the Basilar and Middle Cerebral Arteries and Heart Rate Variability in Normal Subjects.Simultaneous impairment of intracranial and peripheral artery vasoreactivity in CADASIL patients.Endothelial-Vascular Smooth Muscle Cells Interactions in Atherosclerosis
P2860
Q26851816-5E8858FD-514D-40EA-AB17-6EDBED59D3E7Q30382428-3FC477D2-3C58-43CD-933A-CED5EF302176Q30403470-1E9332F5-2C97-47AD-AE00-6F87182674F4Q30880425-52366FE0-F853-409B-AF4A-B26B7B91EFAAQ36153314-1B04DDC5-9093-429D-AAB7-53C31D1ACE96Q36288849-3CF3B0B2-30D0-427B-AC3D-20C65ECBF0ABQ36459076-92E12D83-A9B1-4CE6-9A94-E279EEF971A2Q37390709-D8A52AE9-F000-4560-BE53-D3C820DB63A2Q37390715-8CE78944-576E-445A-B432-18F4F3108697Q37542635-5D08B896-8928-4866-B1CB-E3B21433CBF0Q37581975-1F18CA63-71F3-4B3E-8357-C7E195D8FA16Q37793683-88967B21-E86D-45F8-9E1D-350CE7486EBBQ38014286-534B51F9-AFBE-4DF4-A2E1-0BF3C3FE9703Q38125646-CE5980C8-1867-4373-B702-AE3BA4254594Q38186763-6F5A8AD8-7AD6-4A03-94AA-88F158ADE0D2Q38225366-61F3A038-5D1E-4635-AE6A-7249DBB45739Q38435087-16E905F8-27E7-4DB2-828B-44A22660374CQ48769144-A4A830FE-C385-4D78-B2E0-01C569AE9F52Q58571918-DD9A16FE-4779-40FF-934E-A6D6CB1D5FF4
P2860
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.
@en
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.
@nl
type
label
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.
@en
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.
@nl
prefLabel
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.
@en
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.
@nl
P2093
P2860
P1433
P1476
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.
@en
P2093
Nils Peters
Thomas Pfefferkorn
Tobias Freilinger
P2860
P2888
P304
P356
10.1007/S00415-008-0876-9
P577
2008-06-13T00:00:00Z